ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • 2026 ACR/ARP PRSYM
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 049

Novel Insights of Brain MRI Features in Neonatal Lupus Erythematosus with Hydrocephalus

Sirada Panupattanapong and Andrew Zeft, Department of Pediatric Rheumatology, Cleveland Clinic Children's Hospital, Cleveland, OH

Meeting: 2026 Pediatric Rheumatology Symposium

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
Session Information

Date: Thursday, March 19, 2026

Title: Posters: Clinical and Therapeutic Aspects I

Session Time: 6:00PM-7:00PM

Background/Purpose: Neurologic manifestations in neonatal lupus erythematosus (NLE) are rare and remain poorly characterized. Macrocephaly and hydrocephalus have been reported in approximately 10% of cases, yet these features often go unrecognized or underexplored. While previous studies have described findings from head ultrasonography and brain CT imaging, brain MRI characteristics in NLE have not been reported to date. This gap underscores the need for a deeper understanding of the neuroimaging features associated with the condition.

Methods: We reviewed brain MRI images of two infants diagnosed with NLE and hydrocephalus who were hospitalized at our institution. Both infants demonstrated rapid increases in head circumference (HC), progressing from approximately the 10th percentile at birth to above the 99th percentile at the time of MRI. The mothers of both infants had a confirmed diagnosis of Sjögren’s syndrome. Available head ultrasonography and brain CT images were also analyzed to correlate with the brain MRI findings. Clinical data were reviewed to provide context for the imaging findings and to investigate potential associations with their clinical presentations.

Results: The first brain MRI was performed on a 2-month-old infant who was hospitalized following a rapid progression of HC. The brain MRI revealed diffuse enlargement of the subarachnoid space and all ventricles, with normal brain parenchyma and no abnormal signal in white or grey matter. No evidence of brain atrophy or prior hemorrhage was observed (Figure 1).
The second brain MRI was performed on a 3-month-old infant with history of intrauterine growth restriction (IUGR), born pre-term at 34 weeks gestation, who was hospitalized for respiratory distress and brief cardiac arrest. The brain MRI demonstrated diffuse cerebral white matter atrophy with preserved grey matter, bilateral subdural cerebrospinal (CSF) collections and diffuse enlargement of the subarachnoid spaces. Ventricles were within normal size, and no evidence of acute hemorrhage was observed (Figure2).
Interestingly, the diagnosis of NLE for both infants was confirmed during hospitalization via skin biopsy of their characteristic neonatal lupus rash, which presented at the time of admission. Over time, their HC returned to within the normal growth curve. Both cases are now 5 years old, exhibiting normal developmental milestones with no neurological sequelae.

Conclusion: This study provides the first reported descriptions of brain MRI findings in infants with NLE, highlighting distinct imaging features such as diffuse enlargement of subarachnoid spaces, ventricular abnormalities, and white matter atrophy. These findings expand the understanding of neuroimaging characteristics in NLE. Further research is needed to explore the clinical implications and long-term outcomes of these early neuroimaging abnormalities in NLE.

MRI brain T2 image of a 2-month-old NLE infant with rapid progression of head circumference.Supporting image 1Axial T2 images (A & B) and coronal T2 images (C) demonstrated diffuse enlargement of subarachnoid space and ventricles. Normal signal of grey and white matter.

MRI brain T2 image of a 3-month-old NLE infant, pre-term at 34 weeks gestationSupporting image 2Axial T2 images (A & B) and coronal T2 images (C) demonstrated brain diffuse cerebral white matter atrophy with preserved grey matter, and diffuse enlargement of the subarachnoid spaces. (C) bilateral subdural CSF collections.


Disclosures: S. Panupattanapong: None; A. Zeft: Lixte, 8, Merck/MSD, 8, Sobi, 1, Teva, 8.

To cite this abstract in AMA style:

Panupattanapong S, Zeft A. Novel Insights of Brain MRI Features in Neonatal Lupus Erythematosus with Hydrocephalus [abstract]. Arthritis Rheumatol. 2026; 78 (suppl 3). https://acrabstracts.org/abstract/novel-insights-of-brain-mri-features-in-neonatal-lupus-erythematosus-with-hydrocephalus/. Accessed .
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to 2026 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/novel-insights-of-brain-mri-features-in-neonatal-lupus-erythematosus-with-hydrocephalus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to PRYSM are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 6:00 PM CT on March 18. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology